BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 12173004)

  • 21. Co-occurrence of atypical endometriosis, subserous uterine leiomyomata, sactosalpinx, serous cystadenoma and bilateral hemorrhagic corpora lutea in a perimenopausal adipose patient taking tamoxifen (20 mg/day) for invasive lobular breast cancer.
    Ebert AD; Rosenow G; David M; Mechsner S; Magalov IS; Papadopoulos T
    Gynecol Obstet Invest; 2008; 66(3):209-13. PubMed ID: 18645252
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Primary endodermal sinus tumor of the endometrium presenting as "recurrent" endometrial adenocarcinoma.
    Patsner B
    Gynecol Oncol; 2001 Jan; 80(1):93-5. PubMed ID: 11136577
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Does tamoxifen use affect prognosis in breast cancer patients who develop endometrial cancer?
    McCaul KA
    Obstet Gynecol; 2005 Jan; 105(1):217-8; author reply 218-9. PubMed ID: 15625169
    [No Abstract]   [Full Text] [Related]  

  • 24. [Endometrial cancers arising in polyps associated with tamoxifen use].
    Mbatsogo BA; Le Bouëdec G; Michy T; Bourdel N; Fouilloux G; Dauplat J
    Gynecol Obstet Fertil; 2005 Dec; 33(12):975-9. PubMed ID: 16321556
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A clinicopathologic study on patients with endometrial cancer after adjuvant tamoxifen treatment for breast cancer: a single center experience.
    Ravazoula P; Androutsopoulos G; Zyli P; Michail G; Kardamakis DM; Kourounis G
    Breast J; 2006; 12(6):578-84. PubMed ID: 17238994
    [No Abstract]   [Full Text] [Related]  

  • 26. Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study.
    Fisher B; Costantino JP; Wickerham DL; Cecchini RS; Cronin WM; Robidoux A; Bevers TB; Kavanah MT; Atkins JN; Margolese RG; Runowicz CD; James JM; Ford LG; Wolmark N
    J Natl Cancer Inst; 2005 Nov; 97(22):1652-62. PubMed ID: 16288118
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tamoxifen use and endometrial lesions: hysteroscopic, histological, and immunohistochemical findings in postmenopausal women with breast cancer.
    Dibi RP; Zettler CG; Pessini SA; Ayub AV; de Almeida SB; da Silveira GP
    Menopause; 2009; 16(2):293-300. PubMed ID: 19034048
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Histological analysis of endometrial polyps in breast cancer patients treated with tamoxifen (nolvadex)].
    Ivanova V; Karaivanov M; Raĭcheva S; Marinov E; Gorchev G
    Akush Ginekol (Sofiia); 2004; 43(2):33-6. PubMed ID: 15185527
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Tamoxifen treatment and malignant endometrial tumors--what's new?].
    Perlman S; Vaisbuch E; Ben-Arie A
    Harefuah; 2006 Mar; 145(3):219-22, 244. PubMed ID: 16599321
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Radiation therapy plus tamoxifen versus tamoxifen alone after breast-conserving surgery in postmenopausal women with stage I breast cancer: a decision analysis.
    Punglia RS; Kuntz KM; Lee JH; Recht A
    J Clin Oncol; 2003 Jun; 21(12):2260-7. PubMed ID: 12805324
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Virilizing ovarian tumor of low malignant potential associated with antecedent tamoxifen use for breast cancer.
    Surbek DV; Hoesli I; Torhorst J; Almendral AC; Dellas A; Holzgreve W
    Gynecol Oncol; 1998 Mar; 68(3):293-6. PubMed ID: 9570983
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Postoperative adjuvant chemotherapy followed by adjuvant tamoxifen versus nil for patients with operable breast cancer: a randomised phase III trial of the European Organisation for Research and Treatment of Cancer Breast Group.
    Morales L; Canney P; Dyczka J; Rutgers E; Coleman R; Cufer T; Welnicka-Jaskiewicz M; Nortier J; Bogaerts J; Therasse P; Paridaens R; ;
    Eur J Cancer; 2007 Jan; 43(2):331-40. PubMed ID: 17134892
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [A case regarded as an occult breast cancer treated without mastectomy].
    Kawashima T; Miyazawa Y; Sakata H; Matsubara H; Ryu M; Ochiai T
    Gan To Kagaku Ryoho; 2005 Jun; 32(6):825-8. PubMed ID: 15984524
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Physicians' assessments of adjuvant tamoxifen's effectiveness in older patients with primary breast cancer.
    Lash TL; Gurwitz JH; Silliman RA
    J Am Geriatr Soc; 2005 Nov; 53(11):1889-96. PubMed ID: 16274369
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinicopathologic study of 56 patients with endometrial cancer during or after adjuvant tamoxifen use for their breast cancers.
    Hachisuga T; Saito T; Kigawa J; Ohwada M; Yamazawa K; Yasue A; Iwasaka T; Sugiyama T; Kita T; Nagai N
    Gynecol Oncol; 2004 Oct; 95(1):139-44. PubMed ID: 15385123
    [TBL] [Abstract][Full Text] [Related]  

  • 36. DNA-methylation of the homeodomain transcription factor PITX2 reliably predicts risk of distant disease recurrence in tamoxifen-treated, node-negative breast cancer patients--Technical and clinical validation in a multi-centre setting in collaboration with the European Organisation for Research and Treatment of Cancer (EORTC) PathoBiology group.
    Maier S; Nimmrich I; Koenig T; Eppenberger-Castori S; Bohlmann I; Paradiso A; Spyratos F; Thomssen C; Mueller V; Nährig J; Schittulli F; Kates R; Lesche R; Schwope I; Kluth A; Marx A; Martens JW; Foekens JA; Schmitt M; Harbeck N;
    Eur J Cancer; 2007 Jul; 43(11):1679-86. PubMed ID: 17601725
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Carcinoid tumor of the uterine corpus. A case report.
    González-Bosquet E; González-Bosquet J; García Jiménez A; Gil A; Xercavins J
    J Reprod Med; 1998 Sep; 43(9):844-6. PubMed ID: 9777628
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effectiveness of adjuvant tamoxifen therapy among older women with early stage breast cancer.
    Owusu C; Lash TL; Silliman RA
    Breast J; 2007; 13(4):374-82. PubMed ID: 17593042
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metachronus endometrial carcinoma in a seventy five year old woman with carcinoma of the left breast treated with tamoxifen.
    Abdus-Salam AA; Moharson-Bello IA; Eriba LO; Abdus-Salam RA
    Afr J Med Med Sci; 2013 Sep; 42(3):271-5. PubMed ID: 24579390
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Response to commentary on endometrial cancer deaths in tamoxifen-treated breast cancer patients.
    Patterson JS; Plourde PV; Milbauer A
    J Clin Oncol; 1996 Oct; 14(10):2886-7. PubMed ID: 8874352
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.